Population
Tumours
Design
Review
Authors
Loading...
Ang-2 remains investigational for tumor angiogenesis; leaves open prospective trials before any clinical consideration.
The shift in the Ang-1:Ang-2 ratio towards Ang-2 in tumours promotes a pro-angiogenic state, highlighting Ang-2 as a potential therapeutic target.
Tait et al. (2004) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: